Using self-assembled nanomaterials to inhibit the formation of metastatic cancer stem cell colonies in vitro

Cell Transplantation

Volumn 20, Issue 1, 2011, Pages 127-131

  Ling, Patrick M T ^a   Cheung, Sunny W H ^a   Tay, David K C ^a   Ellis Behnke, Rutledge G ^a,b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Nanomedicine; Prostate cancer; Self assembling peptide; Stem cell

Indexed keywords

NANOMATERIAL; SELF ASSEMBLED MONOLAYER;

ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL ELONGATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; NANOSTRUCTURES; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATIC NEOPLASMS;

EID: 79952520420     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X532783     Document Type: Article

References (15)

1. Chaudhary, P. M.; Roninson, I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66(1):85-94; 1991.
2. Diaz, L. K.; Wiley, E. L.; Venta, L. A. Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am. J. Roentgenol. 173(5):1303-1313; 1999.
3. Ellis-Behnke, R. G.; Liang, Y. X.; Guo, J.; Tay, D. K.; Schneider, G. E.; Teather, L. A.; Wu, W.; So, K. F. Forever young: How to control the elongation, differentiation, and proliferation of cells using nanotechnology. Cell Transplant. 18(9):1047-1058; 2009.
4. Ellis-Behnke, R. G.; Liang, Y. X.; You, S. W.; Tay, D. K.; Zhang, S.; So, K. F.; Schneider, G. E. Nano neuro knitting: Peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl. Acad. Sci. USA 103(13):5054-5059; 2006.
5. Fortner, J. G. Inadvertent spread of cancer at surgery. J. Surg. Oncol. 53(3):191-196; 1993.
6. Holtz, M.; Forman, S. J.; Bhatia, R. Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment. Cancer Res. 67(3):1113-1120; 2007.
7. Hope, K. J.; Jin, L.; Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5(7): 738-743; 2004.
8. Hu, X. C.; Chow, L. W. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR. Oncology 59(3):217-222; 2000.
9. Kobayashi, N.; Navarro-Alvarez, N.; Soto-Gutierrez, A.; Kawamoto, H.; Kondo, Y.; Yamatsuji, T.; Shirakawa, Y.; Naomoto, Y.; Tanaka, N. Cancer stem cell research: Current situation and problems. Cell Transplant. 17(1-2):19-25; 2008.
10. Ling, M. T.; Wang, X.; Ouyang, X. S.; Xu, K.; Tsao, S. W.; Wong, Y. C. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 22(29):4498-4508; 2003.
11. Maitland, N. J.; Collins, A. T. Prostate cancer stem cells: A new target for therapy. J. Clin. Oncol. 26(17):2862-2870; 2008.
12. Petrylak, D. P.; Tangen, C. M.; Hussain, M. H.; Lara, Jr., P. N.; Jones, J. A.; Taplin, M. E.; Burch, P. A.; Berry, D.; Moinpour, C.; Kohli, M.; Benson, M. C.; Small, E. J.; Raghavan, D.; Crawford, E. D. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N. Engl. J. Med. 351(15):1513-1520; 2004.
13. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111; 2001.
14. Tannock, I. F.; de Wit, R.; Berry, W. R.; Horti, J.; Pluzanska, A.; Chi, K. N.; Oudard, S.; Theodore, C.; James, N. D.; Turesson, I.; Rosenthal, M. A.; Eisenberger, M. A. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med. 351(15):1502-1512; 2004.
15. Zhou, S.; Schuetz, J. D.; Bunting, K. D.; Colapietro, A. M.; Sampath, J.; Morris, J. J.; Lagutina, I.; Grosveld, G. C.; Osawa, M.; Nakauchi, H.; Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7(9):1028-1034; 2001.